Trueblood Wealth Management’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
7,646
-155
-2% -$22.6K 0.39% 83
2026
Q1
$1.13M Sell
7,801
-321
-4% -$48.7K 0.44% 72
2025
Q4
$1.16M Sell
8,122
-157
-2% -$23.1K 0.45% 70
2025
Q3
$1.27M Buy
8,279
+41
+0.5% +$6.4K 0.5% 67
2025
Q2
$1.31M Sell
8,238
-13
-0.2% -$2.12K 0.55% 57
2025
Q1
$1.41M Buy
8,251
+369
+5% +$61.8K 0.65% 42
2024
Q4
$1.32M Sell
7,882
-37
-0.5% -$6.3K 0.65% 41
2024
Q3
$1.37M Sell
7,919
-5
-0.1% -$849 0.69% 36
2024
Q2
$1.31M Buy
7,924
+137
+2% +$22.4K 0.74% 32
2024
Q1
$1.26M Buy
7,787
+76
+1% +$11.9K 0.72% 36
2023
Q4
$1.13M Buy
+7,711
New +$1.14M 0.71% 39

Other funds holding PG

Trueblood Wealth Management's PG Position: Q2 2026 in Review

Trueblood Wealth Management reduced its Procter & Gamble (PG) stake by 2% in Q2 2026, selling an estimated $22.6K and leaving 7,646 shares worth $1.12M. The position accounts for 0.39% of the portfolio, ranked #83.

Trueblood Wealth Management first reported a position in PG in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.41M in Q1 2025. 4,006 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Trueblood Wealth Management held 7,646 shares of Procter & Gamble worth $1.12M as of Q2 2026.
  • Trueblood Wealth Management sold 155 Procter & Gamble shares in Q2 2026, an estimated $22.6K.
  • Procter & Gamble made up 0.39% of Trueblood Wealth Management's portfolio in Q2 2026, its #83 holding.
  • Trueblood Wealth Management first reported a position in Procter & Gamble in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's Procter & Gamble position peaked at $1.41M in Q1 2025.
  • 4,006 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.